Literature DB >> 9888914

Recent changes: pulmonary medicine.

N Roche1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 9888914      PMCID: PMC1114660          DOI: 10.1136/bmj.318.7177.171

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  47 in total

1.  Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function.

Authors:  A Roy; C Leblanc; L Paquette; H Ghezzo; J Côté; A Cartíer; J L Malo
Journal:  Eur Respir J       Date:  1996-02       Impact factor: 16.671

2.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.

Authors:  V M Keatings; A Jatakanon; Y M Worsdell; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1997-02       Impact factor: 21.405

Review 3.  Lung volume reduction surgery for emphysema.

Authors:  E W Russi; U Stammberger; W Weder
Journal:  Eur Respir J       Date:  1997-01       Impact factor: 16.671

4.  Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.

Authors:  R D Moore; C P Chaulk; R Griffiths; S Cavalcante; R E Chaisson
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

5.  Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.

Authors:  C Jokinen; L Heiskanen; H Juvonen; S Kallinen; K Karkola; M Korppi; S Kurki; P R Rönnberg; A Seppä; S Soimakallio
Journal:  Am J Epidemiol       Date:  1993-05-01       Impact factor: 4.897

6.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.

Authors:  W H Thompson; C P Nielson; P Carvalho; N B Charan; J J Crowley
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

7.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

8.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Authors:  M Levine; M Gent; J Hirsh; J Leclerc; D Anderson; J Weitz; J Ginsberg; A G Turpie; C Demers; M Kovacs
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

9.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

Authors:  M M Koopman; P Prandoni; F Piovella; P A Ockelford; D P Brandjes; J van der Meer; A S Gallus; G Simonneau; C H Chesterman; M H Prins
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

10.  Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.

Authors:  K Fiscella; P Franks
Journal:  JAMA       Date:  1996-04-24       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.